In 2023, Germany's share of corresponding/leading authorship in scientific publications within the fields of endocrinology, diabetes, and metabolism stood at an impressive level, setting the stage for the forecasted data from 2024 onwards. The share is predicted to experience a slight decline from 91.93% in 2024 to 91.86% in 2028, indicating a marginal annual change.
The year-on-year variations portray a subtle yet consistent downward trend with an overall negative trajectory in this share over the forecasted period. The CAGR for this period suggests a stable, albeit slightly diminishing, influence of corresponding/leading authors in these scientific domains in Germany.
Future trends to watch for include:
- Potential shifts in international collaboration impacting authorship patterns.
- Adoption of diversified authorship models in academic publishing.
- Technological advancements that may influence contribution recognition.
